TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30201225

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (100,000 IU bolus followed by 4000 IU cholecalciferol/day for 16 weeks)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study: 28746065

Group type: EXPERIMENTAL
Intervention: PENS T6 with 1200 kcal/d diet
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: PENS T6 with normocaloric diet
Number of subjects: 200

Group type: COMPARATOR
Intervention: Transcutaneous electrical neurostimulation of T11-T12 with 1200 kcal/d diet (placebo)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Only 1200 kcal/d diet
Number of subjects: 200
Study: 26575249

Group type: EXPERIMENTAL
Intervention: Intraoperative neuromonitoring (IONM)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Non-intraoperative neuromonitoring (non-IONM)
Number of subjects: 50
Study: 23910908

Group type: EXPERIMENTAL
Intervention: Gastric acid suppressive medications (AS)
Number of subjects: 0
Study: 21477068

Group type: EXPERIMENTAL
Intervention: Salbutamol (6 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 19678813

Group type: EXPERIMENTAL
Intervention: 5‐ASA‐MMX (2.4 g/day, once daily)
Number of subjects: 331

Group type: COMPARATOR
Intervention: Asacol (2.4 g/day, twice daily)
Number of subjects: 331
Study: 17197641

Group type: EXPERIMENTAL
Intervention: Rofecoxib (50 mg/day; NSAID)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (PLAC)
Number of subjects: 10
Study: 14679295

Group type: EXPERIMENTAL
Intervention: Methotrexate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: D-penicillamine
Number of subjects: 0
Study: 12010161

Group type: EXPERIMENTAL
Intervention: Frios bone trap
Number of subjects: 38

Group type: COMPARATOR
Intervention: Osseous Coagulum Trap
Number of subjects: 38
Study: 9866959

Group type: EXPERIMENTAL
Intervention: Bone fenestration with mallet and gouge without odontotomy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Odontotomy preceding tooth excision
Number of subjects: 100
Study: 7840355

Group type: EXPERIMENTAL
Intervention: Diagnostic instrument developed for the DSM-IV field trial
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Royal Park Multidiagnostic Instrument for Psychosis
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Munich Diagnostic Checklists
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Consensus DSM-III-R diagnosis by expert clinician researchers
Number of subjects: 50
Study: 2171595

Group type: EXPERIMENTAL
Intervention: Chemotherapy and radiotherapy (40 Gy in the chest tumour)
Number of subjects: 53
Study: 350496

Group type: EXPERIMENTAL
Intervention: Co-trimoxazole (6 mg trimethoprim plus 30 mg sulphamethoxazole/kg)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Streptomycin (50 mg/kg)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Neomycin (50 mg/kg)
Number of subjects: 105
Study: 7036289

Group type: EXPERIMENTAL
Intervention: Adjuvant therapy (chemotherapy, immunotherapy, and chemoimmunotherapy)
Number of subjects: 845

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 845
Study: 31058908

Group type: EXPERIMENTAL
Intervention: Home-based monitored exercise using a smart digital garment and wristband, with motivation and reinforcement via text messages.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard CR facility-based exercise.
Number of subjects: 0
Study: 29412514

Group type: EXPERIMENTAL
Intervention: Parent-Implemented Early Start Denver Model (P-ESDM) intervention for 26 weeks, 1.5 hours of parent coaching per week.
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Parent-Implemented Early Start Denver Model (P-ESDM) intervention for 26 weeks.
Number of subjects: 43

Group type: COMPARATOR
Intervention: Community interventions available from communities for 26 weeks.
Number of subjects: 43
Study: 26558446

Group type: EXPERIMENTAL
Intervention: Patellofemoral bracing
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Tibiofemoral bracing
Number of subjects: 204

Group type: COMPARATOR
Intervention: No bracing
Number of subjects: 204
Study: 24911220

Group type: EXPERIMENTAL
Intervention: Propylene Glycol-Free melphalan (PGF-Mel)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Alkeran
Number of subjects: 24
Study: 22315328

Group type: EXPERIMENTAL
Intervention: Ropivacaine 1 ml kg(‐1) 0.2% or 0.35% at an injection speed of 0.25 ml s(‐1)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Ropivacaine 1 ml kg(‐1) 0.2% or 0.35% at an injection speed of 0.5 ml s(‐1)
Number of subjects: 50
Study: 19822404

Group type: EXPERIMENTAL
Intervention: Diclofenac sodium patch
Number of subjects: 153

Group type: COMPARATOR
Intervention: Control (menthol) patch
Number of subjects: 153
Study: 17601378

Group type: EXPERIMENTAL
Intervention: ACEI/ATRA therapy for 62+/−5 months
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: ACEI/ATRA therapy for 62+/−5 months among patients with genotype II
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: ACEI/ATRA therapy
Number of subjects: 75

Group type: COMPARATOR
Intervention: Untreated control group
Number of subjects: 75
Study: 15298525

Group type: EXPERIMENTAL
Intervention: Support group intervention for grandparents
Number of subjects: 97

Group type: COMPARATOR
Intervention: Wait list control group
Number of subjects: 97
Study: 11519502

Group type: EXPERIMENTAL
Intervention: Metronidazole (two 2-g doses, 48 hours apart, repeated at 24 to 29 weeks)
Number of subjects: 617

Group type: COMPARATOR
Intervention: Placebo (two doses, 48 hours apart, repeated at 24 to 29 weeks)
Number of subjects: 617
Study: 9285463

Group type: EXPERIMENTAL
Intervention: Selegiline (10 mg/day) and levodopa
Number of subjects: 16

Group type: COMPARATOR
Intervention: Levodopa alone
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Discontinuation of selegiline
Number of subjects: 16
Study: 8289134

Group type: EXPERIMENTAL
Intervention: 25 mg daily oral doses
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 75 mg daily oral doses
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 125 mg daily oral doses
Number of subjects: 14

Group type: COMPARATOR
Intervention: Crossover design with washout periods of 7 days
Number of subjects: 14
Study: 2951449

Group type: EXPERIMENTAL
Intervention: rHBsAg vaccine (20 micrograms intramuscular dose)
Number of subjects: 40

Group type: COMPARATOR
Intervention: HEPTAVAX-B vaccine (plasma-derived)
Number of subjects: 40
Study: 28294694

Group type: EXPERIMENTAL
Intervention: Intraoral Low-Level Laser Therapy (LLLT)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Transcutaneous Low-Level Laser Therapy (LLLT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (nonactive laser)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Intraoral LLLT
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Transcutaneous LLLT
Number of subjects: 60
Study: 27260639

Group type: COMPARATOR
Intervention: Plaster cast treatment (immobilisation in a below elbow cast for 6 to 10 weeks)
Number of subjects: 438

Group type: EXPERIMENTAL
Intervention: Immediate surgical fixation (using preferred technique and implant)
Number of subjects: 438

Group type: COMPARATOR
Intervention: Plaster cast treatment
Number of subjects: 438

Group type: EXPERIMENTAL
Intervention: Immediate surgical fixation
Number of subjects: 438
Study: 24313610

Group type: EXPERIMENTAL
Intervention: Pericallosal aneurysms
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Middle cerebral artery aneurysms
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Vertebral artery aneurysms
Number of subjects: 250

Group type: COMPARATOR
Intervention: Overall group
Number of subjects: 250
Study: 22100058

Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg/day plus ezetimibe 10 mg/day
Number of subjects: 39

Group type: COMPARATOR
Intervention: Atorvastatin 20 mg/day
Number of subjects: 39
Study: 19499765

Group type: EXPERIMENTAL
Intervention: 90:90s cycle time with 1 chamber sleeve (A)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: 90:90s cycle time with 3 chamber sleeve (B)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: 45:15s cycle time with 1 chamber sleeve (A)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: 45:15s cycle time with 3 chamber sleeve (B)
Number of subjects: 57
Study: 17956583

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide (single intravenous infusion)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Intratumoral bacille Calmette‐Guérin (BCG) immunotherapy
Number of subjects: 49

Group type: COMPARATOR
Intervention: Healthy donors (control group)
Number of subjects: 49
Study: 15899957

Group type: EXPERIMENTAL
Intervention: GLP-1 infusion during hyperglycemic clamp (7 mm)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: GIP infusion during hyperglycemic clamp (7 mm)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Standard meal test
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Fasting and postprandial plasma GLP-1 and GIP levels
Number of subjects: 49
Study: 11531667

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 42

Group type: COMPARATOR
Intervention: Midazolam
Number of subjects: 42
Study: 9495395

Group type: EXPERIMENTAL
Intervention: Clonidine (4 microg/kg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study: 7851072

Group type: EXPERIMENTAL
Intervention: Tight blood pressure control (aim: < 150/85 mmHg)
Number of subjects: 755

Group type: COMPARATOR
Intervention: Less tight blood pressure control (aim: < 180/105 mmHg)
Number of subjects: 755

Group type: EXPERIMENTAL
Intervention: Captopril (ACE inhibitor)
Number of subjects: 755

Group type: EXPERIMENTAL
Intervention: Atenolol (beta-blocker)
Number of subjects: 755
Study: 3256379

Group type: EXPERIMENTAL
Intervention: Cognitive interview
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Affective interview
Number of subjects: 48

Group type: COMPARATOR
Intervention: Waiting period (control)
Number of subjects: 48
Study: 31843832

Group type: EXPERIMENTAL
Intervention: 3D ultrasound measurements (automated and manual)
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Software for automated measurements
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Automation impact on reproducibility
Number of subjects: 225
Study: 29178865

Group type: EXPERIMENTAL
Intervention: Palliative care interventions
Number of subjects: 15
Study: 25427289

Group type: EXPERIMENTAL
Intervention: 5 cm H2O of positive end-expiratory pressure (PEEP)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Zero added PEEP (control group)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Inspiratory pressure above 15 cm H2O
Number of subjects: 47
Study: 23383733

Group type: EXPERIMENTAL
Intervention: Birth plans implemented during antenatal care (ANC)
Number of subjects: 905

Group type: COMPARATOR
Intervention: Control group (no birth plans)
Number of subjects: 905
Study: 22093847

Group type: EXPERIMENTAL
Intervention: Modified cervical plexus block (Group U) with 2% lidocaine and 0.75% ropivacaine
Number of subjects: 110

Group type: COMPARATOR
Intervention: Traditional one‐point method for blocking cervical plexus (Group C)
Number of subjects: 110
Study: 19679444

Group type: EXPERIMENTAL
Intervention: Cross-linked polyethylene (CLPE) against zirconia
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Cross-linked polyethylene (CLPE) against stainless steel
Number of subjects: 94

Group type: COMPARATOR
Intervention: Non-cross-linked polyethylene (non-CLPE) against zirconia
Number of subjects: 94
Study: 17223419

Group type: EXPERIMENTAL
Intervention: Postprocedural heparin (n = 758; median duration 2 days)
Number of subjects: 976

Group type: EXPERIMENTAL
Intervention: Postprocedural heparin (n = 758)
Number of subjects: 976

Group type: COMPARATOR
Intervention: Postprocedural heparin (n = 555)
Number of subjects: 976
Study: 15031785

Group type: EXPERIMENTAL
Intervention: Saquinavir combined with ritonavir
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Saquinavir combined with nelfinavir
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Saquinavir with adefovir-containing regimens
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Saquinavir (general)
Number of subjects: 0
Study: 11520729

Group type: EXPERIMENTAL
Intervention: noninvasive PSV (n‐PSV)
Number of subjects: 12

Group type: COMPARATOR
Intervention: invasive pressure support ventilation (i‐PSV)
Number of subjects: 12
Study: 9808145

Group type: EXPERIMENTAL
Intervention: Paricalcitol (19‐nor‐1alpha,25‐(OH)2D2)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Calcitriol
Number of subjects: 400
Study: 8592662

Group type: EXPERIMENTAL
Intervention: Single dose studies of immediate release products
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multiple dose studies of immediate release products
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single dose studies of sustained release products
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multiple dose studies of sustained release products
Number of subjects: 0

Group type: COMPARATOR
Intervention: Multiple dose studies
Number of subjects: 0

Group type: COMPARATOR
Intervention: Single dose studies
Number of subjects: 0
Study: 2764328

Group type: EXPERIMENTAL
Intervention: PTL airway training protocol (ten-step protocol including proper airway insertion, patient ventilation, and confirmation of tube placement by auscultation)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: PTL airway training protocol
Number of subjects: 32
Study: 1136854

Group type: EXPERIMENTAL
Intervention: Theophyllamine
Number of subjects: 11

Group type: COMPARATOR
Intervention: Norepinephrine
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Theophyllamine (as the only active drug)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Norepinephrine followed by Theophyllamine
Number of subjects: 11

Group type: COMPARATOR
Intervention: Norepinephrine followed by Saline
Number of subjects: 11
Study: 30907035

Group type: EXPERIMENTAL
Intervention: Neiguan point acupuncture combined with amiodarone therapy
Number of subjects: 85

Group type: COMPARATOR
Intervention: Amiodarone therapy alone
Number of subjects: 85
Study: 28645976

Group type: EXPERIMENTAL
Intervention: Plating
Number of subjects: 0

Group type: COMPARATOR
Intervention: Closed reduction and casting
Number of subjects: 0
Study: 25595565

Group type: EXPERIMENTAL
Intervention: Allopurinol 100 mg/d
Number of subjects: 113

Group type: COMPARATOR
Intervention: Control treatment
Number of subjects: 113
Study: 23926662

Group type: EXPERIMENTAL
Intervention: Cold-water immersion (10 x 3 min at 15 degrees C) with mental skills training
Number of subjects: 6

Group type: COMPARATOR
Intervention: Temperate water immersion (27 degrees C)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Cold-water immersion (10 degrees C) during physiological test
Number of subjects: 6
Study: 21277846

Group type: EXPERIMENTAL
Intervention: Electric toothbrush
Number of subjects: 84

Group type: COMPARATOR
Intervention: Manual teethbrushing
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Manual brushing combined with chlorhexidine mouth rinse (0.12%)
Number of subjects: 84
Study: 18259856

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (AC: doxorubicin or epirubicin, plus cyclophosphamide) added to ovarian function suppression/ablation (OFS) and 5 years of tamoxifen
Number of subjects: 174
Study: 17448650

Group type: EXPERIMENTAL
Intervention: Ciclesonide 320 microg once daily
Number of subjects: 474

Group type: COMPARATOR
Intervention: Fluticasone propionate 200 microg twice daily
Number of subjects: 474
Study: 15283939

Group type: EXPERIMENTAL
Intervention: Dydrogesterone (DYD; 10 mg per day)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Medroxyprogesterone acetate (MPA; 10 mg per day)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Nomegestrol acetate (NMG; 5 mg per day)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Norethisterone acetate (NETA; 10 mg per day)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 11694700

Group type: EXPERIMENTAL
Intervention: Oral penicillin V
Number of subjects: 284

Group type: EXPERIMENTAL
Intervention: Intramuscular benzathine penicillin G (BPG)
Number of subjects: 284
Study: 10195515

Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 40

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 40
Study: 1854694

Group type: EXPERIMENTAL
Intervention: Optical correction of hypermetropia from the age of 6 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Consistent wearing of hypermetropic spectacle correction from the age of 6 months
Number of subjects: 0
Study: 6869040

Group type: EXPERIMENTAL
Intervention: Individual therapy (n = 12)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Small group therapy (n = 11)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Large group therapy (n = 11)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Bibliotherapy (n = 12)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Waiting list control (n = 10)
Number of subjects: 56
Study: 31778430

Group type: EXPERIMENTAL
Intervention: Floseal®
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Tranexamic Acid (TXA)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control
Number of subjects: 90
Study: 30394194

Group type: EXPERIMENTAL
Intervention: Active interferential current (AIC) before pilates exercises
Number of subjects: 142

Group type: COMPARATOR
Intervention: Placebo interferential current (PIC) before pilates exercises
Number of subjects: 142
Study: 28728602

Group type: EXPERIMENTAL
Intervention: Robot-assisted training using the InMotion robotic gym system for 45 min, three times/week for 12 weeks
Number of subjects: 720

Group type: EXPERIMENTAL
Intervention: Enhanced upper limb therapy for 45 min, three times/week for 12 weeks
Number of subjects: 720

Group type: COMPARATOR
Intervention: Usual NHS care in accordance with local clinical practice
Number of subjects: 720

Group type: EXPERIMENTAL
Intervention: Robot-assisted training
Number of subjects: 720

Group type: EXPERIMENTAL
Intervention: Enhanced upper limb therapy
Number of subjects: 720

Group type: COMPARATOR
Intervention: Usual NHS care
Number of subjects: 720
Study: 23107436

Group type: EXPERIMENTAL
Intervention: Health contract intervention for 4 weeks
Number of subjects: 43

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 43
Study: 21231840

Group type: EXPERIMENTAL
Intervention: 3D ultrasound
Number of subjects: 10

Group type: COMPARATOR
Intervention: 2D ultrasound
Number of subjects: 10
Study: 19596158

Group type: EXPERIMENTAL
Intervention: Intensity‐Modulated Radiotherapy (IMRT)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Conventional Radiotherapy (CRT)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: IMRT fluence films
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Combined fields
Number of subjects: 6
Study: 17908472

Group type: EXPERIMENTAL
Intervention: T(3) sympathicotomy
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: T(4) sympathicotomy
Number of subjects: 163

Group type: COMPARATOR
Intervention: Control group not applicable
Number of subjects: 163
Study: 15724514

Group type: EXPERIMENTAL
Intervention: Initial depression level at the first interview
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Loneliness level at the second interview
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Loneliness level after bereavement
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Change in loneliness after bereavement
Number of subjects: 184
Study: 11455484

Group type: EXPERIMENTAL
Intervention: Extended lymphadenectomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard operations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Extended operations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bypass or limited operations
Number of subjects: 0
Study: 10403069

Group type: EXPERIMENTAL
Intervention: Rizatriptan 10-mg wafer
Number of subjects: 555

Group type: EXPERIMENTAL
Intervention: Rizatriptan 5-mg wafer
Number of subjects: 555

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 555
Study: 8024907

Group type: EXPERIMENTAL
Intervention: 1% etidocaine 10 ml
Number of subjects: 8

Group type: COMPARATOR
Intervention: 0.9% sodium chloride solution 10 ml
Number of subjects: 8
Study: 2593865

Group type: EXPERIMENTAL
Intervention: 25 micrograms oestradiol (E2)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 50 micrograms oestradiol (E2)
Number of subjects: 20
Study: 798110

Group type: EXPERIMENTAL
Intervention: Steroid treatment (6 mg of stanozolol per day)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (no steroid treatment)
Number of subjects: 21
Study: 31153798

Group type: EXPERIMENTAL
Intervention: Machine learning classifier using a convolutional neural network
Number of subjects: 2000
Study: 30149141

Group type: EXPERIMENTAL
Intervention: Long-term abacus-based mental calculation (AMC) training
Number of subjects: 162

Group type: COMPARATOR
Intervention: Control group (no AMC training)
Number of subjects: 162
Study: 28394217

Group type: EXPERIMENTAL
Intervention: Virtual Reality Exposure Therapy (VRET)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Control Exposure Therapy (CET)
Number of subjects: 85
Study: 23517508

Group type: EXPERIMENTAL
Intervention: Nadroparin 2850 IU/0.3 ml subcutaneously once a day for 12 months
Number of subjects: 284

Group type: COMPARATOR
Intervention: Basic treatment alone (control group)
Number of subjects: 284

Group type: EXPERIMENTAL
Intervention: Nadroparin treatment in older patients
Number of subjects: 284
Study: 23271189

Group type: EXPERIMENTAL
Intervention: BZA 20 mg/CE 0.45 mg
Number of subjects: 507

Group type: EXPERIMENTAL
Intervention: BZA 20 mg/CE 0.625 mg
Number of subjects: 507

Group type: EXPERIMENTAL
Intervention: Raloxifene 60 mg
Number of subjects: 507

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 507
Study: 21471651

Group type: EXPERIMENTAL
Intervention: MET for the GHJ horizontal abductors
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control
Number of subjects: 61
Study: 18164471

Group type: EXPERIMENTAL
Intervention: Traction therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonsurgical interventions
Number of subjects: 0
Study: 16931656

Group type: EXPERIMENTAL
Intervention: Large-dose propofol (Group HiP)
Number of subjects: 54
Study: 12949439

Group type: EXPERIMENTAL
Intervention: Potassium nitrate supplementation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20